BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 32097194)

  • 41. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa.
    Park BJ; Shetty S; Ahlquist A; Greenbaum A; Miller JL; Motsi A; McCarthy K; Govender N;
    Int J STD AIDS; 2011 Apr; 22(4):199-203. PubMed ID: 21515751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
    Maskew M; Brennan AT; Fox MP; Vezi L; Venter WDF; Ehrenkranz P; Rosen S
    PLoS Med; 2020 Aug; 17(8):e1003226. PubMed ID: 32853271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hodgkin's disease associated with HIV infection: clinical characteristics and development. French registry of tumors associated with HIV infection].
    Roithmann S; Tourani JM; Gastaut JA; Brice P; Raphaël M; Dujardin P; Desablens B; Andrieu JM
    Bull Cancer; 1992; 79(9):873-82. PubMed ID: 1486223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
    de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
    HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
    Rosen S; Maskew M; Larson BA; Brennan AT; Tsikhutsu I; Fox MP; Vezi L; Bii M; Venter WDF
    PLoS Med; 2019 Sep; 16(9):e1002912. PubMed ID: 31525187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors affecting survival in children and adolescents with HIV and Hodgkin lymphoma in South Africa.
    Geel JA; Eyal KC; Hendricks MG; Myezo KH; Stones DK; Omar F; Goga Y; van Zyl A; van Emmenes B; Vaithilingum M; Irusen S; Bandini RM; Wedi O; Rowe B; Ballot DE; Metzger ML;
    Leuk Lymphoma; 2021 Dec; 62(12):2854-2863. PubMed ID: 33284043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial.
    Venter WDF; Majam M; Akpomiemie G; Arulappan N; Moorhouse M; Mashabane N; Chersich MF
    BMC Public Health; 2017 Jul; 17(Suppl 3):445. PubMed ID: 28832288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.
    Bock P; Fatti G; Ford N; Jennings K; Kruger J; Gunst C; Louis F; Grobbelaar N; Shanaube K; Floyd S; Grimwood A; Hayes R; Ayles H; Fidler S; Beyers N;
    PLoS One; 2018; 13(4):e0195127. PubMed ID: 29672542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic utility of bone marrow sampling in HIV-infected patients since the advent of highly active antiretroviral therapy.
    Llewelyn MJ; Noursedeghi M; Dogan A; Edwards SG; Miller RF
    Int J STD AIDS; 2005 Oct; 16(10):686-90. PubMed ID: 16212717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spectrum of AIDS defining & non-AIDS defining malignancies in north India.
    Sachdeva RK; Sharma A; Singh S; Varma S
    Indian J Med Res; 2016 May; 143(Supplement):S129-S135. PubMed ID: 27748287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
    Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
    Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy.
    Tirelli U; Spina M; Gaidano G; Vaccher E; Franceschi S; Carbone A
    AIDS; 2000 Aug; 14(12):1675-88. PubMed ID: 10985303
    [No Abstract]   [Full Text] [Related]  

  • 58. Spectrum of malignancies among HIV-infected patients in South India.
    Venkatesh KK; Saghayam S; Devaleenal B; Poongulali S; Flanigan TP; Mayer KH; Kumarasamy N
    Indian J Cancer; 2012; 49(1):176-80. PubMed ID: 22842185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the HIV epidemic and Anti-Retroviral Treatment policy on lymphoma incidence and subtypes seen in the Western Cape of South Africa, 2002-2009: preliminary findings of the Tygerberg Lymphoma Study Group.
    Abayomi EA; Somers A; Grewal R; Sissolak G; Bassa F; Maartens D; Jacobs P; Stefan C; Ayers LW
    Transfus Apher Sci; 2011 Apr; 44(2):161-6. PubMed ID: 21402310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical features in Hodgkin lymphoma patients living with human immunodeficiency virus: A meta-analysis in the antiretroviral therapy era.
    Souza AT; Andrade FR; Sarmento AC; Villarim CC; Araújo-Filho I; Medeiros KS
    Int J STD AIDS; 2024 Jun; ():9564624241259512. PubMed ID: 38905613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.